不对称合成（下）

4.利用手性氧氮杂环庚烷的不对称合成反应我们运用以(S)-脯氨酸或l-4-羟基脯氨酸衍生物所得到的光学活性四氢吡咯衍生物成功地开发了有高选择性的不对称合成反应。在继续进行这类研究过程中,我们设想除四氢吡咯衍生物     

5—羟基色胺受体激动剂（1R,2S）—（一）—2—（2—羟基苯基）—N …

利用手性双哑唑啉与三氟甲磺酸亚铜催化２－甲氧基苯乙烯与重氮乙酸二环己基甲酯的不对称环丙烷化反应合成了手性环丙烷羟酸酯,用氢化氧钠对其进行选择性水解得到全反式环丙烷羟酸,其ｅｅ值ＧＣ测定为８８％。进一步经过Ｃｕｒｔｉｕｓ重排、烷基化等反应及重结晶等步骤合成了光学纯的具有生理活性的环丙胺化合物Ｉａ和Ｉｂ。     

（—）—莰烷磺内酰胺法合成（S）和（R）切叶蚁警戒信息素

本文以樟脑衍生物(-)-莰烷磺内酰胺(2)为原料,经N-烷酰基莰烷-2,10-磺内酚胺(3)与碘代烷的不对称烷基化反应,用二锂代乙基苯基砜取代磺内酰胺助剂以及铝汞还原性脱硫反应等三步合成(S)和(R)一切叶蚁警戒信息素(1),其光学纯度高达95％e.e以上。     

不对称催化氢化制备（S）—（＋）—萘普生：Ⅱ.不对称氢化反应条件

不对称催化氢化制备（Ｓ）－（＋）－萘普生１）Ⅱ．不对称氢化反应条件赵培庆宫照阳（中国科学院兰州化学物理研究所羰基合成与选择氧化国家重点实验室兰州７３００００）关键词萘普生不对称催化氢化反应条件分类号Ｏ６４３．３２不对称催化是分子催化研究中的前沿领域之...     

(1S,2S)-1,2-二苯基乙二胺修饰Ir/SiO2催化苯乙酮及其衍生物不对称加氢（英文）

不添加任何稳定剂,在碱性条件下制备了5%Ir/SiO2催化剂,并用于催化苯乙酮的不对称加氢反应中,详细考察了碱和手性修饰剂种类、氢气压力、反应温度、(1S,2S)-1,2-二苯基乙二胺((1S,2S)-DPEN)浓度对反应的影响.在优化反应条件下,5%Ir/SiO2催化剂表现出较好的反应活性和对映选择性.其中,苯乙酮不对称加氢反应的对映选择性达70%.该催化剂不需要任何稳定剂,制备方法简单,催化性能稳定,通过简单的离心分离即可循环使用.     

旋光性高分子的合成（下）

旋光性高分子的合成（下）刘引烽，华家栋（上海科技大学化学系，上海，２０１８００）４不对称聚合由外消旋手性单体制备旋光性高分子必须通过选择性聚合才能实现。选择性聚合是指外消旋的两个对映异构单体进行聚合时，由于体系中存在着某种不对称的诱导因素，其中之一比...     

(S)-联萘酚钛体系催化3-噻吩铝试剂对酮的不对称加成反应（英文）

含噻吩基团的的手性芳香醇是自然界重要的活性物质,其基本结构单元广泛地存在于生物活性物质和医药中.报道了(S)-联萘酚和Ti(OiPr)_4催化3-噻吩基铝试剂对酮的不对称加成反应,以较高的产率和优异的立体选择性(高达91%ee)得到相应的含有3-噻吩基乙醇.该催化体系具有广泛的适应性,能够适合含有吸电子和供电子基团的各种酮的不对称加成,得到相应的3-噻吩基乙醇.     

Brevibacterium epidermidis催化酮不对称还原胺化合成(S)-手性胺（英文）

光学纯手性胺是一类非常重要的手性化学品,作为手性砌块和手性拆分剂广泛用于医药、农业化学品、精细化学品等产品的合成中.据统计,美国FDA近年来批准的约40%药物中都含有一个或多个手性胺结构单元.胺脱氢酶(AmDH)是由氨基酸脱氢酶改造而来的一类催化酮不对称还原胺化的新酶,其在手性胺的合成中展现出较强的潜力,已引起国内外学术界和工业界的广泛关注.这是因为该酶能够利用廉价的无机铵为胺供体,且具有催化效率高、原子经济性好和环境友好等优点.迄今为止已经有数个高效的胺脱氢酶被成功开发和报道,但是这些通过蛋白质工程改造的胺脱氢酶均为(R)-选择性,因此只能合成(R)-选择性的手性胺,遗憾的是还未见有(S)-选择性胺脱氢酶的报道.因此,本文主要目的是期望从自然环境中鉴定能够不对称还原胺化酮合成(S)-手性胺的微生物,进而从中分离得到能够以无机铵作为胺供体合成(S)-手性胺的(S)-选择性酶.本文首先利用苯乙胺作为唯一氮源,从土壤中筛选能够利用苯乙胺生长的菌株,进而利用苯乙酮作为初筛底物对得到的菌株进行胺化能力筛选,再利用(4-氟苯基)丙酮作为模式底物进行进一步的筛选.幸运的是,我们获得了能够利用无机铵作为胺供体催化(4-氟苯基)丙酮不对称还原胺化合成(S)-4-氟-α-甲基苯乙胺的菌株,经过16S RNA鉴定为表皮短杆菌,命名为B.epidermidis ECU1015.接下来,我们对B.epidermidis ECU1015催化的胺化反应中的关键参数如胺基供体及其最适浓度、反应温度、pH值和底物浓度等进行了优化,确定最佳反应条件:胺供体为NH_4Cl(1.25 mol/L),反应温度为30℃,KPB缓冲液(200 mmol/L,pH7.5),底物浓度10 mmol/L.最后,在最适的反应条件下,我们对B.epidermidis ECU1015催化的底物谱进行了研究.结果表明,该微生物不能催化大位阻芳香酮和链状酮的胺化,对位阻较小的苯乙酮及(4-氟苯基)丙酮具有较好的还原胺化能力,而且对苯环上带有吸电子取代基的酮化合物具有更好的转化效果.经手性分析,所有生成的手性胺均为(S)-构型,产品的光学纯度均99%.B.epidermidis催化酮不对称胺化所形成的产物构型均为(S)-选择性,这不同于已报道的(R)-选择性胺脱氢酶.该菌株的发现为(S)-选择性胺脱氢酶的进一步鉴定奠定了一定的研究基础,相关蛋白的分离纯化工作正在进行.     

固定化酶不对称合成（S）＋—（＋）—布洛芬的研究

能够不对称水解布洛芬乙酯的酵母菌Ｔ１５８固定化在壳聚糖珠中，固定化酵母菌的活力回收达６０％，最适温度为４５℃，半衰期为７５ｄ以上。     

以CyClo（L—Phe—L—His）催化的芳香氰醇不对称合成

以改进的方法合成了环状二肽(CycloL-Phe-L-His),它在苯甲醛和间苯氧基苯甲醛的不对称氰醇化反应中显示了高活性和高对映选择性。研究了各种反应条件对该催化剂活性和选择性的影响,考察了催化剂的回收使用,旋光稳定性和化学稳定性,探索了催化剂结构与性能间的关系。     

Total synthesis of (-)-(6S,7S,8S,9R,10S,2'S)-membrenone-A and (-)-(6S,7S,8S,9R,10S)- membrenone-B and structural assignment of membrenone-C

[reaction: see text] (-)-(6S,7S,8S,9R,10S,2'S)-Membrenone-A and (-)-(6S,7S,8S,9R,10S)-membrenone-B were prepared in 11 steps (3% and 2.4% overall yield, respectively). Key steps included a tin(II)-mediated aldol followed by a syn selective reduction, giving the C7-C9 stereocenters, a second chain extending aldol coupling, and a p-TsOH-promoted cyclization/dehydration giving the common gamma-dihydropyrone precursor. We have thus established that synthetic (-)-(6S,7S,8S,9R,10S,2'S)-membrenone-A, (-)-(6S,7S,8S,9R,10S)-membrenone-B, and (-)-(6S,7S,8S,9R,10S)-membrenone-C are the enantiomers of the natural products.     

Chemoenzymatic synthesis of (S)-hexafluoroleucine and (S)-tetrafluoroleucine

We have developed a short chemoenzymatic synthesis for both (S)-5,5,5,5',5',5'-hexafluoroleucine (Hfl) and (S)-5,5,5',5'-tetrafluoroleucine (Qfl) on gram scale. Qfl was incorporated into a peptide using standard solid-phase peptide synthesis protocols to measure its helix propensity. The helix propensity for Qfl is 0.68 kcal.mol-1 more favorable compared to Hfl.     

Synthesis of dolichol-type (S)-hexa- and (S)-heptaprenols

(R)-1-Phenysulfonyl-2-methylbutan-4-ol has been used as starting material for the stepwise synthesis of the dolichol-related hexa- and heptaprenols (S)-3,7, 11,15,19,23-hexamethyltetraeicosa-6Z,10Z,14E,18E,22-pentaene-1-ol and (S)-3,7, 11,15,19,23,27-heptamethyloctaeicosa-6Z,10Z,14E,18E,22E,26-hexaen-1-ol.Translated from Izvestiya Akademii Nauk SSSR, Seriya Khimicheskaya, No. 9, pp. 2052–2056, September, 1989.     

Asymmetric synthesis of anti-(2S,3S)- and syn-(2R,3S)-diaminobutanoic acid

Conjugate addition of homochiral lithium N-benzyl-N-alpha-methylbenzylamide to tert-butyl (E)-cinnamate or tert-butyl (E)-crotonate and in situ amination with trisyl azide results in the exclusive formation of the corresponding 2-diazo-3-amino esters in > 95% de. Amination of the lithium (E)-enolates of tert-butyl (3S,alphaR)-3-N-benzyl-N-alpha-methylbenzylamino-3-phenylpropanoate or tert-butyl (3S,alphaS)-3-N-benzyl-N-alpha-methylbenzylaminobutanoate with trisyl azide gives the (2R,3R,alphaR)- and (2S,3S,alphaS )-anti-2-azido-3-amino esters in good yields and in 85% de and > 95% de respectively. Alternatively, tert-butyl anti-(2S,3S,alphaS)-2-hydroxy-3-N-benzyl-N-alpha-methylbenzylaminobutanoate may be converted selectively to tert-butyl anti-(2S,3S,alphaS)-2-azido-3-N-benzyl-N-alpha-methylbenzylaminobutanoate by aziridinium ion formation and regioselective opening with azide. Deprotection of tert-butyl (2S,3S,alphaS)-2-azido-3-aminobutanoate via Staudinger reduction, hydrogenolysis and ester hydrolysis furnishes anti-(2S,3S)-diaminobutanoic acid in 98%, de and 98% ee. The asymmetric synthesis of the diastereomeric syn-(2R,3S)-diaminobutanoic acid (98% de and 98% ee) was accomplished via functional group manipulation of tert-butyl anti-(2S,3S,alphaS)-2-hydroxy-3-N-benzyl-N-alpha-methylbenzylaminobutanoate in a protocol involving azide inversion of tert-butyl (2S,3S)-2-mesyloxy-3-N-Boc-butanoate and subsequent deprotection.     

Total synthesis of (S)-(+)-curcudiol, and (S)-(+)- and (R)-(-)-curcuphenol.

A highly enantioselective synthesis of the versatile chiral synthons possessing one stereogenic center, (S)- and (R)-4-aryl-5-hydroxy-(2E)-pentenoate (3) was achieved based on the enzymatic reaction of (+/-)-3 with commercially available lipases MY-30 or OF-360 from Candida rugosa. Application of (S)-3 and (R)-3 to the total syntheses of(S)-curcuphenol (1), (S)-curcudiol (2), and (R)-curcuphenol (1), respectively, is described.     

(S)-美托洛尔的不对称合成

用自制的(S,S)-Salen Co(Ⅲ)OAc催化剂水解动力学拆分外消旋环氧氯丙烷得到高光学纯的(S)-3-氯-1,2-丙二醇和较高光学纯的(R)-环氧氯丙烷。 以(S)-3氯-1,2-丙二醇为手性原料和4-(2-甲氧基乙基)苯酚缩合,再与氯化亚砜反应得环状亚硫酸酯,最后和异丙胺反应得(S)-美托洛尔,光学纯度大于99%。 另外以(R)-环氧氯丙烷为手性原料和4-(2-甲氧基乙基)苯酚反应,再与异丙胺作用得到(S)-美托洛尔,光学纯度大于92%。 (S)-美托洛尔的总收率为53.9%,结构经IR、1H NMR、13C NMR和MS测试技术确证。 该路线原料利用率高,拆分后的2种产物均能用于目标化合物的合成。     

Synthesis of (2S,4S)- and (2S,4R)-5-fluoroleucine and (2S,4S)-[5,5-2H2]-5-fluoroleucine

Syntheses of (2S,4S)- and (2S,4R)-5-fluoroleucine, and, and of (2S,4S)-[5,5-(2)H(2)]-5-fluoroleucine, have been completed. The methodology allows these compounds to be prepared in sufficient quantities for incorporation by solid-state protein synthesis into strategic sites in proteins for folding studies. X-ray structures of the epimers and have been obtained and show the presence of conformational isomerism. The torsion angles between the F-C bond and the main chain are compared with values found in a mutant of the protein ubiquitin in which (2S,4S)-5-fluoroleucine replaces leucine residues 50 and 67 in the native protein.     

Biotransformation of (1S)-2-carene and (1S)-3-carene by Picea abies suspension culture

Biotransformation of (1S)-2-carene and (1S)-3-carene by Picea abies suspension culture led to the formation of oxygenated products. (1S)-2-Carene was transformed slowly and the final product was identified as (1S)-2-caren-4-one. On the other hand, the transformation of (1S)-3-carene was rapid and finally led to the formation of (1S)-3-caren-5-one and (1S)-2-caren-4-one as equally abundant major products. The time-course of the reaction indicates that some products abundant at the beginning of the reaction (e.g. (1S, 3S, 4R)-3,4-epoxycarane and (1R)-p-mentha-1(7),2-dien-8-ol) were consumed by a subsequent transformations. Thus, a precise selection of the biotransformation time may be used for a production of specific compounds.     

Interconversion of (S)-glutamate and (2S,3S)-3-methylaspartate: a distinctive B(12)-dependent carbon-skeleton rearrangement

The interconversion of (S)-glutamate and (2S,3S)-3-methylaspartate catalyzed by B(12)-dependent glutamate mutase is discussed using results from high-level ab initio molecular orbital calculations. Evidence is presented regarding the possible role of coenzyme-B(12) in substrate activation and product formation via radical generation. Calculated electron paramagnetic resonance parameters support experimental evidence for the involvement of substrate-derived radicals and will hopefully aid the future detection of other important radical intermediates. The height of the rearrangement barrier for a fragmentation-recombination pathway, calculated with a model that includes neutral amino and carboxylic acid substituents in the migrating glycyl group, supports recent experimental evidence for the interconversion of (S)-glutamate and (2S,3S)-3-methylaspartate through such a pathway. Our calculations suggest that the enzyme may facilitate the rearrangement of (S)-glutamate through (partial) proton-transfer processes that control the protonation state of substituents in the migrating group.     

S(1S) production following electron impact on thiophosgene (Cl2CS)

A special xenon matrix detector has been used to study the production of S(1S) following controlled electron impact on thiophosgene (Cl2CS) targets over an electron energy range from threshold to 400 eV. Time-of-flight spectroscopy has been used to measure S(1S) fragment kinetic energies. Fragments with energies in excess of 1 eV have been observed. The absolute cross section for S(1S) production reaches a maximum of [1.05+/-0.35] x 10(-18) cm2 at approximately 125 eV impact energy. Two different fragmentation processes, involving triplet and singlet excited states of the parent Cl2CS molecule, have been identified.